RADA Electronic Industries Announces 2014 First Quarter

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
RADA Electronic Industries Announces 2014 First Quarter Results

NETANYA, Israel, June 10, 2014 (GLOBE NEWSWIRE) -- RADA Electronic Industries Ltd. (Nasdaq: RADA ) announced today its financial results for the quarter ended March 31, 2014.

2014 First quarter Results

Revenues for the first quarter of 2014 of $5.4 million remained constant with the Company's revenues in the first quarter of 2013.

Gross Profit totaled $1.6 million, a 91% increase when compared with $0.85 million in the first quarter of 2013.

Operating Expenses totaled $1.2 million, a 24% decrease when compared with $1.5 million in the first quarter of 2013.

Operating Income totaled $0.5 million, compared with an operating loss of $0.7 million first quarter of 2013.

Financial Expenses totaled $293,000, a 38 % decrease when compared with financial expenses of $475,000 in the first quarter of 2013.

As a result, the Company reported net profit of $158,000, or $0.02 per share, for the first quarter of 2014 compared with a net loss of $1,165,000, or $0.13 per share, for the first quarter of 2013.

Management Comment

Commenting on the results, Zvika Alon, RADA's Chief Executive Officer said, "While our revenues in the first quarter were at a similar level to last year's first quarter, we experienced a significant reduction in cost of revenues, operating expenses and financial expenses. The increase in our gross margin is attributable to the significant reduction of low margin programs during the last six months, while the decrease in operating expense is mainly due to reduction in our R&D spending as our Inertial Navigation and Ground Radar products have reached maturity. Our first quarter results, consistent with our fourth quarter 2013 results, indicate that we are maintaining the previously reported trend of improved operating and net profit. These factors, together with the growing revenues generated from Inertial Navigation and Ground Radar products' sales are expected to continue and favorably influence our 2014 results."

About RADA

RADA Electronic Industries Ltd. is an Israel-based defense electronics contractor. The Company specializes in the development, production, and sales of Tactical Land Radar for Force and Border Protection, Inertial Navigation Systems for air and land applications and Avionics Systems and Upgrades.

Note: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Litigation Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results to differ materially. Such risk uncertainties and other factors include, but are not limited to, changes in general economic conditions, risks in product and technology developments, market acceptance of new products and continuing product demand, level of competition and other factors described in the Company's Annual Report on Form 20-F and other filings with the Securities and Exchange Commission.

CONSOLIDATED BALANCE SHEETS
U.S. dollars in thousands, except share and per share data  
     
ASSETS March 31, 2014 December 31, 2013
  Unaudited Audited
CURRENT ASSETS:    
Cash and cash equivalents $1,615 $2,137
Restricted cash 488 1,033
Trade receivables (net of allowance for doubtful accounts of $ 39 and $ 36 at March 31, 2014 and at December 31, 2013 respectively) 4,121 4,890
Costs and estimated earnings in excess of billings on uncompleted contracts 2,103 2,031
Other receivables and prepaid expenses 762 412
Inventories 7,666 6,798
     
Total current assets 16,755 17,301
     
LONG-TERM RECEIVABLES AND OTHER DEPOSITS 1,100 1,133
     
PROPERTY, PLANT AND EQUIPMENT, NET 2,877 2,986
     
GOODWILL 587 587
     
Total assets $21,319 $22,007
     
LIABILITIES AND SHAREHOLDERS' EQUITY    
     
CURRENT LIABILITIES:    
Bank Credit $2,151 $1,887
Trade payables 2,911 2,909
Convertible note and Loans from shareholders, net 7,120 8,307
Other accounts payable and accrued expenses 4,447 4,350
     
Total current liabilities 16,629 17,453
     
LONG-TERM LIABILITIES:    
Accrued severance pay and other long term liability 577 569
     
Total long-term liabilities 577 569
     
RADA SHAREHOLDERS' EQUITY    
Share capital --    
Ordinary shares of NIS 0.015 par value - Authorized: 16,333,333 shares at March 31, 2014 and December 31, 2013; Issued and outstanding: 8,918,647 at March 31, 2014 and at December 31, 2013 respectively. 119 119
Additional paid-in capital 70,884 70,884
Accumulated other comprehensive income 526 547
Accumulated deficit (68,042) (68,200)
     
Total RADA shareholders' equity 3,487 3,350
Non-controlling interest 626 635
     
Total equity 4,113 3,985
     
Total liabilities and equity $21,319 $22,007
     
CONSOLIDATED STATEMENTS OF OPERATIONS
U.S. dollars in thousands, except per share data    
       
  Three months ended Year ended 
  March 31, December 31,
  2014 2013 2013
  (unaudited) (audited)
       
Revenues $5,347 $5,357 $21,761
       
Cost of revenues 3,733 4,510 17,160
       
Gross profit 1,614 847 4,601
       
Operating expenses:      
Research and development 230 471 1,459
Marketing and selling 470 547 1,959
General and administrative 467 521 1,919
       
Total operating expenses 1,167 1,539 5,337
       
Operating profit (loss) 447 (692) (736)
Financial expenses, net 293 475 1,907
       
Net profit (loss) 154 (1,167) (2,643)
       
Less: attributable to Noncontrolling interest 4 2 8
       
Net profit (loss) attributable to RADA Electronic Industries' shareholders $158 $(1,165) $(2,635)
       
Basic and diluted net profit (loss) per share $0.02 $(0.13) $(0.30)
       
Weighted average number of Ordinary shares used for computing basic and diluted net loss per share 8,918,647 8,918,647 8,918,647

Shiri Lazarovich - C.F.O RADA Electronic Industries Ltd. Tel: +972-9-8921111

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 14

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading

Top 5 Most Recently Viewed Articles

Unlocking High Performance: WorkBoard's New AI Enhancements

Updated Category News Views 101

Back in 2024, WorkBoard turned heads with its ambitious AI enhancements designed to overhaul strategy execution. You remember how organizations were struggling to keep their objectives on track? Well, that was the backdrop when WorkBoard stepped in, hoping to redefine the game. AI Capabilities: A Game Changer or Just Hype? At the Accelerate conference that year, buzz...

Continue Reading
Strengthening Leadership for Enhanced AI-Powered Aesthetics

Updated Category News Views 380

Cloud Clinic Enhances Leadership for Future Growth Cloud Clinic, an innovative healthcare technology platform, is embarking on a significant journey to expand its leadership team. This decision comes as the company aims to accelerate its growth and improve patient care across the nation. Strategic Leadership Appointments Leading the charge is John Sandberg, the visionary...

Continue Reading
HKBU Advances Wastewater Treatment with Innovative Technology

Updated Category News Views 220

Transforming Wastewater Treatment with Innovative Membranes Recent advancements by a dedicated research team from Hong Kong Baptist University (HKBU) have led to the creation of a groundbreaking catalytic membrane. This novel technology significantly enhances the effectiveness of wastewater treatment processes using advanced oxidation methods. Such innovations are crucial...

Continue Reading
CleanCore Solutions Successfully Completes Significant Funding Round

Updated Category News Views 255

CleanCore Solutions Completes Major Private Placement Today, CleanCore Solutions, Inc. (NYSE American: ZONE) announced the successful closing of a significant private investment in public equity (PIPE) financing. This funding has raised an impressive $175,000,420, a noteworthy achievement prior to deducting any agent fees or related expenses, utilizing a mix of cash and...

Continue Reading
Understanding Western Alliance Bancorporation's Legal Challenges

Updated Category News Views 181

Background on Western Alliance Bancorporation Western Alliance Bancorporation is a prominent bank holding company, primarily engaged in various banking services. Recently, the firm has come under scrutiny due to allegations concerning misleading business information exchanged with investors. This situation compels attention from current and potential investors alike,...

Continue Reading